Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes

Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes

BackgroundMarkers of bone and extracellular matrix (ECM) remodeling may be associated with adverse outcomes in atherosclerotic cardiovascular disease. Podocan is a newly discovered ECM glycoprotein, previously not studied in a chest pain population. We wanted to study the association between Podocan...

Full description

Bibliographic Details
Main Authors: Thomas Andersen, Thor Ueland, Pål Aukrust, Dennis W. Nilsen, Heidi Grundt, Harry Staines, Frederic Kontny
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
extracellular matrix
chest pain
acute coronary syndrome
risk factors
biomarkers
Podocan
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.867944/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.867944/full

Similar Items